Gemphire Therapeutics Board of Directors, Key People and Executives

Health Care & Life Sciences » Pharmaceuticals | Gemphire Therapeutics Inc.

Gemphire Therapeutics Inc. | Key People and Executives

Charles L. Bisgaier

Chairman & Chief Scientific Officer

Steven R. Gullans

President, Chief Executive Officer & Director

Andrew H. Sassine

Independent Director

Pedro Lichtinger

Independent Director

Kenneth Kousky

Independent Director

P. Kent Hawryluk

Independent Director

Charles L. Bisgaier

Chairman & Chief Scientific Officer

Steven R. Gullans

President, Chief Executive Officer & Director

Jeffrey S. Mathiesen

CFO, Secretary & Principal Accounting Officer

Lee Scott Golden

Chief Medical Officer

Seth Reno

Chief Commercial Officer

Rebecca Bakker-Arkema

Vice President-Drug & Clinical Development

Andrew H. Sassine

Independent Director

Pedro Lichtinger

Independent Director

Kenneth Kousky

Independent Director

P. Kent Hawryluk

Independent Director

View Profile

Address	17199 North Laurel Park Drive Livonia Michigan 48152 United States
Employees	-
Website	http://www.gemphire.com
Updated	07/08/2019
Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the provision of treatment options for cardiometabolic diseases including dyslipidemia and NASH. It offers a small molecule formulated as a tablet product under the Gemcabene brand.